MDT - Medtronic PLC Stock Price, Fair Value and News

$101.97-0.06 (-0.06%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

MDT Price Action

Last 7 days

-2.9%

Last 30 days

13.1%

Last 90 days

9.8%

Trailing 12 Months

19.0%

MDT RSI Chart

MDT Valuation

Market Cap

130.7B

Price/Earnings (Trailing)

27.46

Price/Sales (Trailing)

3.76

EV/EBITDA

16.53

Price/Free Cashflow

25.11

MDT Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

MDT Fundamentals

MDT Revenue

Revenue (TTM)

34.8B

Rev. Growth (Yr)

6.64%

Rev. Growth (Qtr)

4.46%

MDT Earnings

Earnings (TTM)

4.8B

Earnings Growth (Yr)

8.19%

Earnings Growth (Qtr)

31.23%

MDT Profitability

EBT Margin

16.40%

Return on Equity

9.74%

Return on Assets

5.21%

Free Cashflow Yield

3.98%

MDT Investor Care

Dividend Yield

2.77%

Dividend/Share (TTM)

2.82

Buy Backs (1Y)

0.02%

Diluted EPS (TTM)

3.71

MDT Alerts

1 major insider sales recently.

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	33.2B	33.5B	34.2B	34.8B
2024	32.3B	32.4B	32.6B	33.0B
2023	30.8B	31.2B	31.6B	32.0B
2022	31.8B	31.7B	31.1B	30.8B
2021	27.9B	30.1B	31.6B	31.8B
2020	31.1B	28.9B	27.9B	27.9B
2019	30.6B	30.6B	30.7B	30.9B
2018	29.7B	30.0B	29.9B	30.4B
2017	29.4B	29.7B	29.9B	29.6B
2016	28.6B	28.8B	28.7B	29.0B
2015	17.5B	20.3B	23.3B	26.0B
2014	16.9B	17.0B	17.2B	17.4B
2013	16.5B	16.6B	16.7B	16.8B
2012	0	16.2B	16.3B	16.4B

Get all data in R, Python etc through our Historical Stock Data APIs

About Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.

CEO	Mr. Geoffrey Straub Martha
WEBSITE	medtronic.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	65535

Medtronic PLC Frequently Asked Questions

What is the ticker symbol for Medtronic PLC? What does MDT stand for in stocks?

MDT is the stock ticker symbol of Medtronic PLC. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Medtronic PLC (MDT)?

As of Wed Dec 03 2025, market cap of Medtronic PLC is 130.73 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MDT stock?

You can check MDT's fair value in chart for subscribers.

Is Medtronic PLC a good stock to buy?

The fair value guage provides a quick view whether MDT is over valued or under valued. Whether Medtronic PLC is cheap or expensive depends on the assumptions which impact Medtronic PLC's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MDT.

What is Medtronic PLC's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, MDT's PE ratio (Price to Earnings) is 27.46 and Price to Sales (PS) ratio is 3.76. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MDT PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Medtronic PLC's stock?

In the past 10 years, Medtronic PLC has provided 0.027 (multiply by 100 for percentage) rate of return.